Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Targeting cancer stem cells via dendritic-cell vaccination.

Teitz-Tennenbaum S, Wicha MS, Chang AE, Li Q.

Oncoimmunology. 2012 Nov 1;1(8):1401-1403.

2.

Cancer stem cell vaccination confers significant antitumor immunity.

Ning N, Pan Q, Zheng F, Teitz-Tennenbaum S, Egenti M, Yet J, Li M, Ginestier C, Wicha MS, Moyer JS, Prince ME, Xu Y, Zhang XL, Huang S, Chang AE, Li Q.

Cancer Res. 2012 Apr 1;72(7):1853-64. doi: 10.1158/0008-5472.CAN-11-1400.

3.

DNA vaccines targeting the encoded antigens to dendritic cells induce potent antitumor immunity in mice.

Cao J, Jin Y, Li W, Zhang B, He Y, Liu H, Xia N, Wei H, Yan J.

BMC Immunol. 2013 Aug 14;14:39. doi: 10.1186/1471-2172-14-39.

4.
5.

Local secretion of IL-12 augments the therapeutic impact of dendritic cell-tumor cell fusion vaccination.

Tan C, Dannull J, Nair SK, Ding E, Tyler DS, Pruitt SK, Lee WT.

J Surg Res. 2013 Dec;185(2):904-11. doi: 10.1016/j.jss.2013.06.045. Epub 2013 Jul 17.

PMID:
23891424
6.

Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.

Wei H, Wang S, Zhang D, Hou S, Qian W, Li B, Guo H, Kou G, He J, Wang H, Guo Y.

Clin Cancer Res. 2009 Jul 15;15(14):4612-21. doi: 10.1158/1078-0432.CCR-08-3321. Epub 2009 Jul 7.

7.

Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens.

Xu Q, Liu G, Yuan X, Xu M, Wang H, Ji J, Konda B, Black KL, Yu JS.

Stem Cells. 2009 Aug;27(8):1734-40. doi: 10.1002/stem.102.

8.
9.

Vaccination with dendritic cells pulsed with apoptotic cells elicits effective antitumor immunity in murine hepatoma models.

Hayashi T, Nakao K, Nagayama Y, Saitoh O, Ichikawa T, Ishikawa H, Hamasaki K, Eguchi K, Ishii N.

Int J Oncol. 2005 May;26(5):1313-9.

PMID:
15809723
10.

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.

Zitvogel L, Mayordomo JI, Tjandrawan T, DeLeo AB, Clarke MR, Lotze MT, Storkus WJ.

J Exp Med. 1996 Jan 1;183(1):87-97.

11.

In vivo delivery of antigens by adenovirus dodecahedron induces cellular and humoral immune responses to elicit antitumor immunity.

Villegas-Mendez A, Garin MI, Pineda-Molina E, Veratti E, Bueren JA, Fender P, Lenormand JL.

Mol Ther. 2010 May;18(5):1046-53. doi: 10.1038/mt.2010.16. Epub 2010 Feb 23.

12.

Targeting a mimotope vaccine to activating Fcgamma receptors empowers dendritic cells to prime specific CD8+ T cell responses in tumor-bearing mice.

Gil M, Bieniasz M, Wierzbicki A, Bambach BJ, Rokita H, Kozbor D.

J Immunol. 2009 Nov 15;183(10):6808-18. doi: 10.4049/jimmunol.0900364. Epub 2009 Oct 21.

13.

Targeting the immunoregulator SRA/CD204 potentiates specific dendritic cell vaccine-induced T-cell response and antitumor immunity.

Yi H, Guo C, Yu X, Gao P, Qian J, Zuo D, Manjili MH, Fisher PB, Subjeck JR, Wang XY.

Cancer Res. 2011 Nov 1;71(21):6611-20. doi: 10.1158/0008-5472.CAN-11-1801. Epub 2011 Sep 13.

14.

The use of dendritic cells for peptide-based vaccination in cancer immunotherapy.

Salem ML.

Methods Mol Biol. 2014;1139:479-503. doi: 10.1007/978-1-4939-0345-0_37. Review.

PMID:
24619701
15.

Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells.

Höltl L, Rieser C, Papesh C, Ramoner R, Herold M, Klocker H, Radmayr C, Stenzl A, Bartsch G, Thurnher M.

J Urol. 1999 Mar;161(3):777-82.

PMID:
10022683
16.
17.

HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination.

Chan T, Sami A, El-Gayed A, Guo X, Xiang J.

Gene Ther. 2006 Oct;13(19):1391-402. Epub 2006 May 25.

PMID:
16724093
18.

Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells.

Suzuki T, Fukuhara T, Tanaka M, Nakamura A, Akiyama K, Sakakibara T, Koinuma D, Kikuchi T, Tazawa R, Maemondo M, Hagiwara K, Saijo Y, Nukiwa T.

Clin Cancer Res. 2005 Jan 1;11(1):58-66.

19.

Supplemental Content

Support Center